Dr. Wissam discusses the highlights on adjuvant therapy in cutaneous melanoma

Podcasts

June 2022

Dr. Wissam discusses the highlights on adjuvant therapy in cutaneous melanoma

Dr. Yacine Wissam, CHU de Charleroi, Charleroi, Belgium

In this podcast, Dr. Yacine Wissam will summarise the highlights on adjuvant therapy in cutaneous melanoma as presented by several speakers during the EADO 2022 congress.

“This podcast was brought to you by the publisher of the Belgian Journal of Medical Oncology (BJMO) in partnership with Novartis”

SUBSCRIBE TO BJMO ONCOTALKS SERIES

Table of Contents:

Podcasts

Dr. Wissam discusses the highlights on adjuvant therapy in cutaneous melanoma

Dr. Yacine Wissam, CHU de Charleroi, Charleroi, Belgium

All podcasts

Dr. Wissam discusses the highlights on adjuvant therapy in cutaneous melanoma

Dr. Yacine Wissam, CHU de Charleroi, Charleroi, Belgium

Prof. Hoeller about the potential role for adjuvant therapy in the treatment of intermediate risk melanoma patients

Prof. Dr. Christopher Hoeller, Medical University of Vienna, Vienna, Austria

Prof. Nikkels on the TELESPOT Project: a Belgian teledermoscopy system in primary healthcare centres for early detection of skin cancer

Prof. Dr. Arjen Nikkels, CHU de Liège, Liège, Belgium

Prof. Annelies Janssens discusses the 3-year overall survival data of the phase III, randomized controlled CASPIAN trial (Dutch)

Prof. Sebahat Ocak discusses the 3-year overall survival data of the phase III, randomized controlled CASPIAN trial (French)

Prof. Dr. Marc Van den Eynde about the results of the PRECONNECT study

Prof. dr. Marc Van den Eynde, digestive oncologist at the Clinique Universitaires Saint-Luc in Brussels

Prof. Dr. Eric Van Cutsem about the highlights from ESMO World Congress on Gastrointestinal Cancer